Esperion Therapeutics, Inc.
ESPR
15 insider filings · Latest: Jun 17, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Jun 18 8:06 PM | Benjamin LookerChief Legal Officer | Sale | 11,824 | $3.16 | $37.3K | 667,524(D) | View → |
| Jun 17, 2026 | Jun 18 8:06 PM | Sheldon L. KoenigDirector, President and CEO | Sale | 53,588 | $3.16 | $169.1K | 2,119,111(D) | View → |
| Jun 17, 2026 | Jun 18 8:05 PM | Benjamin HalladayChief Financial Officer | Sale | 10,773 | $3.15 | $34.0K | 702,829(D) | View → |
| Jun 17, 2026 | Jun 17 7:34 PM | Koenig Sheldon L. | Proposed Sale | 53,588 | $3.15 | $169.1K | — | View → |
| Jun 17, 2026 | Jun 17 7:23 PM | Halladay Benjamin | Proposed Sale | 10,773 | $3.15 | $34.0K | — | View → |
| Jun 17, 2026 | Jun 17 7:11 PM | Looker Benjamin | Proposed Sale | 11,824 | $3.15 | $37.3K | — | View → |
| Mar 17, 2026 | Mar 18 8:13 PM | Benjamin LookerChief Legal Officer | Sale | 5,708 | $2.70 | $15.4K | 679,348(D) | View → |
| Mar 17, 2026 | Mar 18 8:13 PM | Sheldon L. KoenigDirector, President and CEO | Sale | 25,578 | $2.72 | $69.5K | 2,172,699(D) | View → |
| Mar 17, 2026 | Mar 18 8:12 PM | Benjamin HalladayChief Financial Officer | Sale | 6,424 | $2.71 | $17.4K | 713,602(D) | View → |
| Mar 17, 2026 | Mar 17 7:19 PM | Halladay Benjamin | Proposed Sale | 6,424 | $2.70 | $17.4K | — | View → |
| Mar 17, 2026 | Mar 17 7:17 PM | Looker Benjamin | Proposed Sale | 5,708 | $2.70 | $15.4K | — | View → |
| Mar 17, 2026 | Mar 17 7:12 PM | Koenig Sheldon L. | Proposed Sale | 25,578 | $2.72 | $69.6K | — | View → |
| Jan 20, 2026 | Jan 21 10:17 PM | Benjamin LookerGeneral Counsel | Sale | 1,689 | $2.88 | $4.9K | 384,216(D) | View → |
| Jan 20, 2026 | Jan 20 8:14 PM | Looker Benjamin | Proposed Sale | 1,689 | $2.88 | $4.9K | — | View → |
| Dec 17, 2025 | Dec 17 8:52 PM | Koenig Sheldon L. | Proposed Sale | 48,244 | $3.67 | $177.2K | — | View → |
| Dec 17, 2025 | Dec 17 8:26 PM | Looker Benjamin | Proposed Sale | 6,517 | $3.67 | $23.9K | — | View → |
| Dec 17, 2025 | Dec 17 8:18 PM | Halladay Benjamin | Proposed Sale | 7,337 | $3.67 | $26.9K | — | View → |
| Oct 17, 2025 | Oct 17 7:13 PM | Looker Benjamin | Proposed Sale | 1,248 | $2.62 | $3.3K | — | View → |
| Sep 17, 2025 | Sep 17 7:37 PM | Koenig Sheldon L. | Proposed Sale | 28,427 | $2.79 | $79.2K | — | View → |
| Sep 17, 2025 | Sep 17 7:30 PM | Halladay Benjamin | Proposed Sale | 7,046 | $2.81 | $19.8K | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Mar 16 8:20 PM | Benjamin LookerChief Legal Officer | Grant/Award | 269,230 | $2.44 | 269,230(D) | View → |
| Mar 13, 2026 | Mar 16 8:20 PM | Sheldon L. KoenigDirector, President and CEO | Grant/Award | 647,460 | $2.44 | 647,460(D) | View → |
| Mar 13, 2026 | Mar 16 8:19 PM | Benjamin HalladayChief Financial Officer | Grant/Award | 221,270 | $2.44 | 221,270(D) | View → |